Arrow Electronics, Inc. provides products, services, and solutions to industrial and commercial users of electronic components and enterprise computing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Global Components and Global Enterprise Computing Solutions. The Global Components segment markets and distributes electronic components comprising semiconductor products and related services; interconnect, passive, and electromechanical products, including capacitors, resistors, potentiometers, power supplies, relays, switches, and connectors; and computing and memory products, as well as other products and services. The Global Enterprise Computing Solutions segment offers computing solutions, such as datacenter, cloud, security, and analytics solutions. This segment also provides access to various services, including engineering and integration support, warehousing and logistics, marketing resources, and authorized hardware and software training. It serves original equipment manufacturers, value-added resellers, managed service providers, contract manufacturers, and other commercial customers. The company was founded in 1935 and is based in Centennial, Colorado.

Arrow Electronics, Inc.

Arrowhead Pharmaceuticals, Inc. (($ARWR)) has held its Q3 earnings call. Read on for the main highlights of the call. Arrowhead Pharmaceuticals’ la...

Arrowhead Pharmaceuticals Earnings Call Signals Confident Expansion

Analysts are intrested in these 5 stocks: ( ($BBY) ), ( ($YARW) ), ( ($AAPL) ), ( ($LNTH) ) and ( ($INTU) ). Here is a breakdown of their recent


Best Buy, Yarrow, Apple, Lantheus, Intuit Trending With Analysts

Chardan Capital analyst Keay Nakae maintained a Buy rating on Arrowhead Pharmaceuticals yesterday and set a price target of $115.00. According to T...

Arrowhead Pharmaceuticals (ARWR) Gets a Buy from Chardan Capital

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on PTC Therapeutics (PTCT) and Arrowhead Pharmaceutical...

Analysts’ Top Healthcare Picks: PTC Therapeutics (PTCT), Arrowhead Pharmaceuticals (ARWR)

Yarrow Bioscience ( ($YARW) ) has shared an announcement. On July 27, 2026, Yarrow Bioscience closed its merger with VYNE Therapeutics, completed a...

Yarrow Bioscience Completes VYNE Merger and Nasdaq Debut

Golden Arrow Resources ( ($TSE:GRG) ) has shared an update. Graphene Manufacturing Group has signed a distribution agreement with Blackwoods, Austr...

GMG Taps Blackwoods to Drive National Rollout of Graphene Products in Australia

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Claritev (CTEV), Ionis Pharmaceuticals (IONS) and Ar...

Analysts Offer Insights on Healthcare Companies: Claritev (CTEV), Ionis Pharmaceuticals (IONS) and Arrowhead Pharmaceuticals (ARWR)

Arrowhead Pharmaceuticals stock saw major gains after the company announced new results from a Phase 3 trial.


Arrowhead Pharmaceuticals (ARWR) Stock Soars on Strong Phase 3 Trial Results

Arrowhead Pharmaceuticals, Inc. ($ARWR) announced an update on their ongoing clinical study. Arrowhead’s new first-in-human study of ARO-033 aims t...

Arrowhead’s ARO-033 First-in-Human Trial: What Early Safety Progress Means for ARWR Investors

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Arrowhead Pharmaceuticals (ARWR), Otsuka Holdings Co...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ARW	$213.99	0.00%	388.18K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ARW	$213.99	0%	388.18K
3
4
5
6

ARW

Get Arrow Electronics, Inc. Data in Excel

Get Arrow Electronics, Inc. Data in Excel